GlassScriptPhysician profile
Abdul Shahin
NPI 1316314636
$8,896.06
in general payments reported to CMS, 2019-2025
29 companies · $1,670 in 2025
The $1,670 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,147 · 2022: $1,744 · 2023: $1,767 · 2024: $2,567 · 2025: $1,670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,920 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,919.95 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $2,018.65 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,074.56 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Philips North America LLC | $1,037.45 | 2022-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Abbvie INC. | $1,003.43 | 2021-2025 | |
| Novo Nordisk INC | $802.57 | 2021-2025 | Ozempic, Rybelsus |
| Baxter Healthcare | $448.83 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Vest System Model 205 Acute Care, Hillrom - Metaneb System |
| Glaxosmithkline, LLC. | $447.91 | 2021-2025 | Trelegy Ellipta, Nucala |
| Lilly USA, LLC | $292.86 | 2021-2025 | Jardiance, Mounjaro, Emgality |
| Amarin Pharma, INC. | $286.53 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $191.29 | 2021-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $158.85 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $137.39 | 2021-2025 | Xifaxan, Trulance |
| Ironwood Pharmaceuticals, INC | $125.00 | 2024 | |
| Amgen INC. | $119.18 | 2022-2025 | Repatha, Repatha, Otezla |
| Ardelyx, INC. | $113.12 | 2024-2025 | Ibsrela |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inogen, INC. | $105.70 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Actelion Pharmaceuticals US, INC. | $79.99 | 2024 | Opsumit, Uptravi |
| Mylan Specialty L.P. | $70.74 | 2024 | Yupelri |
| Horizon Therapeutics Plc | $65.14 | 2021 | |
| Viatris Specialty LLC | $57.00 | 2025 | Yupelri |
| Exact Sciences Corporation | $56.21 | 2023-2025 | Cologuard Collection Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $50.28 | 2025 | Caplyta |
| Neurocrine Biosciences, INC. | $28.19 | 2025 | |
| Global Blood Therapeutics, INC. | $24.47 | 2021 | |
| Insmed, INC. | $24.10 | 2025 | Brinsupri, Arikayce |
| Metacel Pharmaceuticals LLC | $22.04 | 2024 | Ozobax |
| Advanced Respiratory, INC | $21.62 | 2021 | |
| Novartis Pharmaceuticals Corporation | $20.42 | 2022 | |
| United Therapeutics Corporation | $12.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdul Shahin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.